More access beyond metro elite patients: With lower pricing, treatment may gradually become more realistic for middle-income Indian families too
Peer review Peer review information Nature Cancer thanks Andrew Hoy, Michael Pollak, ngela Valverde and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
It simultaneously targets GLP-1, GIP, and glucagon receptors, showing superior results in preclinical studies for weight management, energy expenditure, body composition, hepatic lipid metabolism, NASH/NAFLD, thermogenesis, and long-term metabolic homeostasis
316 , F231F240 (2019)
GH is known to increase GFR
Some GLP-1 agonists have demonstrated cardiovascular risk reduction in clinical trials